Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2017 - 2026)

Takeda Pharmaceutical has reported Goodwill & Intangibles for 10 years, with the latest figure at $58.2 billion in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles fell 3.39% year-over-year to $58.2 billion in Q2 2026; TTM through Jun 2026 was $58.2 billion, a 3.39% decrease from a year earlier, with the FY2026 full-year figure at $58.8 billion, changed 0.09% from the prior year.
• Goodwill & Intangibles was $58.2 billion for Q2 2026 at Takeda Pharmaceutical, down from $58.8 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $70.8 billion in Q1 2022, with the low at $58.2 billion in Q2 2026.
• Average Goodwill & Intangibles over 5 years is $63.5 billion, with a median of $62.3 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles dropped 14.52% in 2022, then climbed 4.07% in 2023.
• Over 5 years, Goodwill & Intangibles stood at $59.9 billion in 2022, then climbed by 4.07% to $62.3 billion in 2023, then advanced by 0.04% to $62.3 billion in 2024, then slipped by 3.35% to $60.2 billion in 2025, then retreated by 3.35% to $58.2 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $58.2 billion (Q2 2026), $58.8 billion (Q1 2026), and $60.2 billion (Q4 2025), per Business Quant data.